Whether hypoxanthine production from inosine confers higher protection from T2D in individuals carrying these polymorphisms, by inhibiting the activation of poly(ADP-ribose) polymerase39 and thus increasing TCF7L2-mediated GLP-1 production and activity40, needs to be further explored. The gene discussed is TCF7L2; the disease is type 2 diabetes mellitus.